BioSpace News Archive

Business

BioNTech and Genevant Sciences Sign Strategic mRNA-Focused Partnership in Rare Diseases

Partnership combines Genevant’s industry-leading delivery technology and BioNTech’s cutting-edge mRNA drug discovery platform to develop best-in-class therapeutics

July 10, 2018
·
5 min read
Policy

Transgene and Tasly Biopharmaceuticals Conclude Strategic Agreements for the Rights of Transgene’s Virus-Based Immunotherapies TG6002 and TG1050 in Greater China

Transgene to receive $48 million paid in newly created Tasly Biopharmaceuticals shares

July 10, 2018
·
9 min read
Genetown

Cancer Discovery Features H3 Biomedicine Paper Highlighting Effects of Selective Estrogen Receptor Covalent Antagonists (SERCAs) in ERα Wild-Type and Mutant Breast Cancer Models

Next-generation endocrine therapy exhibits differentiated mechanism of action versus standard-of-care therapies and potently inhibits the ERα pathway

July 10, 2018
·
4 min read
Policy

Sprint Bioscience Strengthens the Vps34 Project by Patenting the use of Newly Developed Biomarkers in Immune-oncology

Sprint Bioscience has developed biomarkers for the company’s anti-cancer project, Vps34.

July 10, 2018
·
2 min read
Pharm Country

Filament BioSolutions Announces Collaboration with Ajinomoto for the Development of FB-2710 for Radiation-Induced Oral MucositisFilament is expanding its product pipeline to include multiple oncology co-therapies

Filament BioSolutions announced continued progress in the development of its lead product FB-2710

July 10, 2018
·
3 min read
Drug Development

ProMIS Neurosciences to Present Preclinical Data on Alzheimer’s Disease Therapeutic Antibody PMN310 at Alzheimer’s Association International Conference

PMN310 Shows Potential for Best in Class Amyloid-Beta Oligomer Selectivity

July 10, 2018
·
4 min read
Bio NC

Avera Health Increases Labor & Delivery Patient Safety with new PeriWatch® Decision Support System

Avera Health now uses real-time trend analysis for the mothers and babies in its care

July 10, 2018
·
3 min read
Drug Development

Anti-PD-L1 Immunotherapy Plus ABRAXANE® Significantly Reduced the Risk of Disease Worsening or Death in Patients with Metastatic or Locally Advanced Triple Negative Breast Cancer in Phase III IMpassion130 Study

First Phase III study to demonstrate a statistically significant progression-free survival improvement in first-line metastatic triple negative breast cancer (TNBC)

July 10, 2018
·
14 min read
Business

Medical Therapeutics Moving Forward with New Office Location with Established 2700 Patient Database

View Systems, Inc. announced that its new medical division, Medical Therapeutics, a concierge medical service providing sexual health therapies is opening a new medical facility in Pittsburgh, PA to continue servicing clients from this area.

July 10, 2018
·
2 min read
Business

PROVECTUS BIOPHARMACEUTICALS CLINICAL TRIALS UPDATE PROVIDED AT EUROPEAN POST-CHICAGO MELANOMA/SKIN CANCER MEETING

Provectus announced that a clinical trials update was provided at the 8th European Post-Chicago Melanoma/Skin Cancer Meeting, held in Munich, Germany from June 28-29.

July 10, 2018
·
3 min read